Global Monoclonal Antibodies in Veterinary Health Market Report 2022: Rising Frequency of Canine Atopic Dermatitis Fueling Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Monoclonal Antibodies in Veterinary Health Market size, trends and growth opportunities, by application, by animal type, by end-user by region and forecast to 2027.” report has been added to from ResearchAndMarkets.com offer.

Global Monoclonal Antibodies in Veterinary Health Market Size, Trends & Growth Opportunities, By Application (Dermatology, Pain, Others), By Animal Type (Dogs, Others), By End User (Veterinary Hospitals, Others.) By region and forecast to 2027.

Global Market for Monoclonal Antibodies in Veterinary Health

Global Monoclonal Antibodies Market in Veterinary Health was valued at USD 0.77 Billion in 2021 which is projected to reach USD 2.47 Billion by 2027 at a CAGR of 16.27% from 2021 to 2027.

Monoclonal antibodies are drugs that act like your own antibodies and can help prevent your symptoms from getting worse and can prevent hospitalization due to worsening symptoms of COVID-19. This is NOT a vaccine replacement; rather, it is used to treat your current COVID-19 infection. The increasing prevalence of atopic dermatitis, along with the increasing rate of pet adoption, is driving the market expansion. Additionally, increasing R&D expenditure by market players for the development of cancer treatments is expected to fuel the expansion of the market over the forecast period.

Market factors

The increasing frequency of canine atopic dermatitis is also expected to play a driving role in the expansion of the market. Canine atopic dermatitis is a genetic clinical disease that affects domestic dogs. Additionally, atopic dermatitis is the most common cause of itchy allergic skin in dogs.

According to a study by Frontiers Media SA published in October 2020, the disease should affect 10 to 15% of the canine population. According to the publication, this figure is expected to increase over time. Market players like Zoetis have products like Cytopoint, the first monoclonal antibody treatment for allergic and atopic dermatitis.

Market segmentation

The global market for monoclonal antibodies in veterinary health is segmented into application, animal type, distribution channel, and growth system. By application such as dermatology, pain, others. By type of animal such as dogs, others. By the end user such as veterinary hospitals, others.

Regional analysis

The global monoclonal antibodies market in veterinary health is segmented into five regions such as North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. During the forecast period, the North America veterinary health monoclonal antibody market is expected to grow at the fastest CAGR. This is due to the various programs launched by the government and the commercial sector, as well as the growing popularity of pet insurance.

Additionally, the presence of prominent organizations in the United States is expected to support the growth of the market. According to the North American Pet Health Insurance Association, Inc., the pet insurance industry has experienced significant growth of 23.4% in recent years. Additionally, at the end of 2020, approximately 3.45 million pets were covered in North America.

The Asia-Pacific market is expected to grow at the fastest CAGR over the forecast period, owing to the growing emergence of local businesses and growing number of veterinary hospitals and clinics. Furthermore, the growing adoption of companion animals, along with better knowledge of their diseases and availability of treatment choices, is expected to drive the expansion of the market.

Market Taxonomy

By request

By animal type

Per end user

  • Veterinary hospitals

  • Others

By region

  • North America

  • Latin America

  • Europe

  • China

  • Asia Pacific

  • Middle East and Africa

Key questions addressed by the report

  • What are the key opportunities in the global Monoclonal Antibodies in Veterinary Health market?

  • What will be the growth rate from 2020 to 2027?

  • Which segment/region will experience the highest growth?

  • What are the factors that will impact/driving the market?

  • What is the competitive landscape in the industry?

  • What is the role of key players in the value chain?

Main topics covered:

1. Introduction

2 Research methodology

3 Executive Summary

4 Global Monoclonal Antibodies in Veterinary Health Market Outlook

5 Global Monoclonal Antibodies in Veterinary Health Market, by Application

6 Global Monoclonal Antibodies in Veterinary Health Market, by Animal Type

7 Global Monoclonal Antibodies in Veterinary Health Market, by End User

8 Global Market for Monoclonal Antibodies in Veterinary Health, by Region

9 North America Monoclonal Antibodies in Veterinary Healthcare Market Analysis and Forecast (2021-2027)

10 Europe Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)

11 Asia-Pacific Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)

12 Latin America Monoclonal Antibodies in Veterinary Healthcare Market Analysis and Forecast (2021-2027)

13 Middle East Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)

14 Competitive Analysis

15 company profiles

Companies cited

  • Zoetis

  • Merck & Co Inc.

  • Elanco

  • Boehringer Ingelheim GmbH

  • Indian Immunologicals Ltd

  • Virbac

For more information about this report visit https://www.researchandmarkets.com/r/ly7fmq

About Hector Hedgepeth

Check Also

Want to be a veterinarian? Here’s what you need to know

This is Science Week, a week-long event held in Ireland every November, celebrating science in …